REGISTERED
on 30 Jul 2024
Last Applicant/ Owned by
Marie-Curie-Straße 1
Rheinbach
DE
53359
Serial Number
97677631 filed on 15th Nov 2022
Registration Number
7459774 registered on 30th Jul 2024
Correspondent Address
LEIGH ANN LINDQUIST
Filing Basis
No Filing Basis
Disclaimer
NO DATA
CLICKMER
Scientific research and development for third parties, especially in the fields of diagnostics, pharmaceuticals, chemistry, biology, biochemistry and biotechnology; scientific and technological services, namely, providing medical research information and scientific research information, feasibility studies, testing services and analysis services in the fields of diagnostics, pharmaceuticals, chemi Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Medical and veterinary services; medical and veterinary diagnostic services, namely, laboratory services for diagnosis of diseases and genetic defects
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Scientific research and development for third parties, especially in the fields of diagnostics, pharmaceuticals, chemistry, biology, biochemistry and biotechnology; scientific and technological services, namely, providing medical research information and scientific research information, feasibility studies, testing services and analysis services in the fields of diagnostics, pharmaceuticals, chemistry, biology, biochemistry and biotechnology; scientific laboratory and chemical, biological, biochemical, biotechnological and pharmaceutical analytical services
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Chemical, biological, biochemical, biotechnological and pharmaceutical products and preparations, namely, DNA/RNA oligonucleotides, antibodies, nucleic acids, proteins, lipids, polysaccharides, enzymes, peptides, microorganisms, cell cultures and cells as well as fragments, fractions and derivatives thereof, for medical, veterinary or pharmaceutical purposes, namely, for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination and immunostimmulation; therapeutic agents for medical, veterinary and pharmaceutical purposes, namely, for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination and immunostimmulation, medicaldiagnostic agents for medical, veterinary and pharmaceutical purposes; preparations for health care, namely, medicinal preparations for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination and immunostimmulation; Medicines for for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction and pain as well as for gene therapy, vaccination and immunostimmulation, vaccines
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Chemical preparations, biological preparations and biochemical preparations for industrial and scientific use; Biotechnological preparations, namely, cells, proteins, enzymes, peptides, cultures of microorganisms for industrial and scientific use; Chemical preparations, biological preparations, biochemical preparations and biotechnological preparations, namely, diagnostic preparations other than for medical or veterinary purposes; Chemical additives for use in the manufacture of pharmaceuticals; Chemical, biological, biochemical and biotechnological products and preparations for use in the manufacturing of pharmaceuticals, namely, DNA/RNA oligonucleotides, antibodies, nucleic acids, proteins, lipids, polysaccharides, enzymes, peptides, microorganisms, cell cultures and cells as well as fragments, fractions and derivatives thereof
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97677631
Mark Type
No Service Mark
Attorney Docket Number
No S26278
44D Filed
Yes
44D Current
No
44E filed
No
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 15th Aug 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 15th Aug 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 15th Aug 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 15th Aug 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 15th Aug 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 15th Aug 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| 30th Jul 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 30th Jul 2024 | REGISTERED-PRINCIPAL REGISTER |
| 14th May 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 14th May 2024 | PUBLISHED FOR OPPOSITION |